Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend/template update. No study information or user-facing content appears to be affected.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4; this reflects a new release label rather than any change to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, representing a minor administrative update to the page documentation.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now indicates recruitment is closed and introduces new guidance sections for reading the study record and joining the study, along with a formatting change to the Intervention/Treatment heading and a revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check78 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation/metadata.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.